8/F, 35 QRC Building, No.35 Queens Road, Central, Hong Kong
hkmagicure@gmail.com
  • Selumetinib (Koselugo)

    ---Indications and Usage--- Koselugo is a kinase inhibitor indicated for the treatment of pediatric patients 2 years of age and older with neurofibroma...

    Neurofibroma
  • Of 1Page1Record